Xenon Pharmaceuticals Inc.
For the period ended Jun 30, 2025. Filed Aug 11, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 11, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
(a) Exhibits.
| Exhibit · Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Number | Description of Document | Form | File No. | Exhibit | Filing Date |
| 3.1 | Articles of the Company. | 10-Q | 001-36687 | 3.1 | December 15, 2014 |
| 3.1A | Articles of Amendment to the Articles of the Company, creating the Series 1 Preferred Shares. | 8-K | 001-36687 | 3.1 | March 28, 2018 |
| 3.2 | Amended and Restated By-laws of the Company. | 10-Q | 001-36687 | 3.2 | December 15, 2014 |
| 10.1 | Form of Restricted Share Unit Award Agreement. | ||||
| 10.2# | Employment Agreement, dated June 2, 2025, by and between the Company and Darren Cline. | ||||
| 31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a). | ||||
| 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a). | ||||
| 32.1* | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350. | ||||
| 32.2* | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350. | ||||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document with Embedded Linkbases Document | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
#Indicates management contract or compensatory plan.
*The Certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Xenon Pharmaceuticals Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.
-65-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.